Mar 21, 2022 / 05:30PM GMT
Laurence Alexander - Jefferies LLC, Research Division - VP & Equity Research Analyst
Hello, everybody, and good afternoon. Thank you for joining us for another in our series on -- our virtual series on synthetic biology and its practical applications. Joining me for this discussion is FMC's Chief Technology Officer, Dr. Kathleen Shelton, and also Zack Zaki from Investor Relations.
Before we dive in, I'd just like to mention, as we have done with the other calls today, if you have any questions, please e-mail me at [email protected] or you can use the web interface. If you have that website up, please feel free to enter your questions that way.
I guess without any further ado, Kathleen, maybe just jump right in. Could you give a brief sketch first of all, of how you became involved in researching biologicals and crop science at DuPont and then, obviously, sort of how that then brought you over to FMC?
Questions and Answers:
Kathleen A. Shelton - FMC Corporation - Executive VP & CTOSure, Laurence. And first, let me start
Trustpilot
